Arbutus Biopharma Corporation (ABUS)
NASDAQ · Healthcare
Arbutus Biopharma Corporation Shareholder Equity 2011–2025
Arbutus Biopharma Corporation annual shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Arbutus Biopharma Corporation shareholder equity as of December 31, 2025: 76.6M, a 21.35% decrease year-over-year.
- Arbutus Biopharma Corporation shareholder equity for 2025 were 76.6M, a 21.35% decrease from 2024.
- Arbutus Biopharma Corporation shareholder equity for 2024 were 97.4M, a 8.16% decrease from 2023.
- Arbutus Biopharma Corporation shareholder equity for 2023 were 106.0M, a 22.53% decrease from 2022.
- Arbutus Biopharma Corporation shareholder equity for 2022 were 136.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Arbutus Biopharma Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $77 |
| 2024 | $97 |
| 2023 | $106 |
| 2022 | $137 |
| 2021 | $169 |
| 2020 | $102 |
| 2019 | $73 |
| 2018 | $200 |
| 2017 | $182 |
| 2016 | $203 |
| 2015 | $548 |
| 2014 | $88 |
| 2013 | $59 |
Arbutus Biopharma Corporation Shareholder Equity — FAQ
Arbutus Biopharma Corporation (ABUS) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABUS's shareholder equity history?
The chart and table above show Arbutus Biopharma Corporation's shareholder equity by year and by quarter, including the growth rate.